How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure? Commentary

Archives of Disease in Childhood

Volumn 94, Issue 7, 2009, Pages 559-561

  Tebruegge, M ^a,b   Pantazidou, A ^b   Curtis, N ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES ZOSTER IMMUNOGLOBULIN; ANTISERUM; VARICELLA ZOSTER IMMUNE GLOBULIN; VARICELLA-ZOSTER IMMUNE GLOBULIN;

CHICKENPOX; CLINICAL TRIAL; DRUG EFFICACY; HEALTH SURVEY; HERPES; HUMAN; NOTE; OUTCOME ASSESSMENT; PERINATAL DRUG EXPOSURE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; EVIDENCE BASED MEDICINE; NEWBORN; PASSIVE IMMUNIZATION; REVIEW;

CHICKENPOX; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNE SERA; IMMUNIZATION, PASSIVE; INFANT, NEWBORN;

EID: 67649697286     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.154542     Document Type: Note

References (19)

1. Salisbury D, Ramsay M, Noakes K, eds. Immunisation against Infectious Diseases. London: Department of Health, 2006:421-422
2. American Academy of Pediatrics. The Red Book: 2006 report of the Committee on Infectious Diseases. 27th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2006:711-725
3. Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 1989;2:371-373
4. Carter PE, Duffy P, Lloyd DJ. Neonatal varicella infection. Lancet 1986;2:1459-1460
5. Hanngren K, Grandien M, Granstrom G. Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis 1985;17:343-347
6. Evans EB, Pollock TM, Cradock-Watson JE, et al. Human anti-chickenpox immunoglobulin in the prevention of chickenpox. Lancet 1980;1:354-356
7. Winsnes R. Efficacy of zoster immunoglobulin in prophylaxis of varicella in high-risk patients. Acta Paediatr Scand 1978;67:77-82.
8. Centers for Disease Control (The Advisory Committee on Immunization Practices (ACIP)). Recommendations for the use of VZIG 2007. MMWR Morb Mortal Wkly Rep 2007;56(RR-4):1-40.
9. Department of Human Services. The Australian Immunisation Handbook. 9th edn. Canberra, ACT: DHS, 2008.
10. Public Health Agency of Canada. Canadian immunization guide. 7th edn. Ottawa: PHA, 2006.
11. Ständige Impfkommission Deutschland (STIKO)/ Robert Koch Institut. Varizellen (Windpocken), Herpes zoster (Gürtelrose). Available from www.rki.de/cln-100/nn-504678/DE/Content/Infekt/EpidBull/Merkblaetter/ Ratgeber-Mbl-Varizellen.html (accessed 24 April 2009).
12. Nathwani D, Maclean A, Conway S, et al. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998;36(Suppl 1):59-71.
13. Meyers JD. Congenital varicella in term infants: risk reconsidered. J Infect Dis 1974;129:215-217
14. DeNicola LK, Hanshaw JB. Congenital and neonatal varicella. J Pediatr 1979;94:175-176
15. Brunell PA, Ross A, Miller LH, et al. Prevention of varicella by zoster immune globulin. N Engl J Med 1969;280:1191-1194
16. Hanngren K, Falksveden L, Grandien M, et al. Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients. Scand J Infect Dis 1983;15:327-334
17. Bakshi SS, Miller TC, Kaplan M, et al. Failure of varicella-zoster immunoglobulin in modification of severe congenital varicella. Pediatr Infect Dis 1986;5:699-702.
18. Reynolds L, Struik S, Nadel S. Neonatal varicella: varicella zoster immunoglobulin (VZIG) does not prevent disease. Arch Dis Child Fetal Neonatal Ed 1999;81:F69-70.
19. Holland P, Isaacs D, Moxon ER. Fatal neonatal varicella infection. Lancet 1986;2:1156.